Paul Campanelli Insider Trading $PRX PAR PHARMACEUTICAL COMPANIES, INC.
Get free email notifications about insider trading for Paul Campanelli.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul Campanelli. Paul Campanelli is Chief Executive Officer in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Chief Operating Officer in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres-Generics in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres-Par Pharmaceutical in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres. - Generics in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres. Generic Prod Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres.-Generics in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, President-Generics in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP; President - Generics in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Exec VP, Pres Generic Prod Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Exec VP, Pres Generics Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Exec VP, Pres-Generics Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Director in Endo International plc ($ENDP) and Group President, Generics in Endo International plc ($ENDP) and President & CEO in Endo International plc ($ENDP) and President, CEO in Endo International plc ($ENDP) and President, Par Pharmaceutical in Endo International plc ($ENDP).
Paul Campanelli in PAR PHARMACEUTICAL COMPANIES, INC.
Trading Symbol: PRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul Campanelli: Chief Executive Officer, Chief Operating Officer, EVP, Pres-Par Pharmaceutical, EVP; President - Generics, EVP, Pres. - Generics, EVP, Pres-Generics, EVP, Pres.-Generics, EVP, President-Generics, EVP, Pres. Generic Prod Div, Exec VP, Pres Generic Prod Div
Holdings: 0 shares
Latest Transaction: Oct 02 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Paul Campanelli in PAR PHARMACEUTICAL COMPANIES, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 32.76 | 50,875 | 1,666,665 | 0 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 36.54 | 17,789 | 650,010 | 0 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 27.71 | 17,593 | 487,502 | 0 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 13.06 | 27,000 | 352,620 | 0 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 13.06 | 22,771 | 297,389 | 27,000 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 10.99 | 34,290 | 376,847 | 0 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 24.27 | 3,175 | 77,057 | 0 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 33.62 | 4,497 | 151,189 | 0 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 42.14 | 8,970 | 377,996 | 0 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 0.00 | 25,438 | 0 | 0 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 0.00 | 25,438 | 0 | 0 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Sell | D | 50.00 | 46,017 | 2,300,850 | 0 | 46 K to 0 (-100.00 %) |
Jan 13 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Operating Off ... | Payment of Exercise | F | 35.65 | 1,102 | 39,286 | 46,106 | 47.2 K to 46.1 K (-2.33 %) |
Jan 09 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Operating Off ... | Option Exercise | A | 0.00 | 25,438 | 0 | 25,438 | |
Jan 09 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Operating Off ... | Option Exercise | A | 32.76 | 50,875 | 1,666,665 | 50,875 | |
Jan 09 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Operating Off ... | Option Exercise | A | 0.00 | 25,438 | 0 | 25,438 | |
Jan 09 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Operating Off ... | Payment of Exercise | F | 34.01 | 806 | 27,412 | 47,118 | 47.9 K to 47.1 K (-1.68 %) |
Jan 06 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Operating Off ... | Payment of Exercise | F | 32.17 | 1,062 | 34,165 | 47,924 | 49 K to 47.9 K (-2.17 %) |
Nov 22 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Operating Off ... | Payment of Exercise | F | 29.56 | 7,009 | 207,186 | 49,794 | 56.8 K to 49.8 K (-12.34 %) |
Mar 24 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Payment of Exercise | F | 29.00 | 3,039 | 88,131 | 56,803 | 59.8 K to 56.8 K (-5.08 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.81 | 100 | 3,081 | 59,842 | 59.9 K to 59.8 K (-0.17 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.80 | 300 | 9,240 | 59,942 | 60.2 K to 59.9 K (-0.50 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.79 | 723 | 22,261 | 60,242 | 61 K to 60.2 K (-1.19 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.78 | 434 | 13,359 | 60,965 | 61.4 K to 61 K (-0.71 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.77 | 2,335 | 71,848 | 61,399 | 63.7 K to 61.4 K (-3.66 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.76 | 5,097 | 156,784 | 63,734 | 68.8 K to 63.7 K (-7.41 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.75 | 24,732 | 760,509 | 68,831 | 93.6 K to 68.8 K (-26.43 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.75 | 200 | 6,149 | 93,563 | 93.8 K to 93.6 K (-0.21 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.74 | 2,500 | 76,850 | 93,763 | 96.3 K to 93.8 K (-2.60 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.73 | 1,100 | 33,803 | 92,263 | 93.4 K to 92.3 K (-1.18 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.72 | 300 | 9,216 | 97,363 | 97.7 K to 97.4 K (-0.31 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.71 | 600 | 18,426 | 97,663 | 98.3 K to 97.7 K (-0.61 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.70 | 800 | 24,560 | 98,263 | 99.1 K to 98.3 K (-0.81 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.69 | 700 | 21,483 | 99,063 | 99.8 K to 99.1 K (-0.70 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.68 | 600 | 18,408 | 99,763 | 100.4 K to 99.8 K (-0.60 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.67 | 100 | 3,067 | 100,363 | 100.5 K to 100.4 K (-0.10 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.66 | 200 | 6,132 | 100 | 300 to 100 (-66.67 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.65 | 300 | 9,195 | 100,663 | 101 K to 100.7 K (-0.30 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.65 | 300 | 9,194 | 100,963 | 101.3 K to 101 K (-0.30 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.64 | 1,275 | 39,066 | 101,263 | 102.5 K to 101.3 K (-1.24 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.63 | 1,637 | 50,141 | 102,538 | 104.2 K to 102.5 K (-1.57 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.62 | 930 | 28,477 | 104,175 | 105.1 K to 104.2 K (-0.88 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.61 | 400 | 12,244 | 105,105 | 105.5 K to 105.1 K (-0.38 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.60 | 100 | 3,060 | 105,505 | 105.6 K to 105.5 K (-0.09 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.60 | 100 | 3,060 | 105,605 | 105.7 K to 105.6 K (-0.09 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.59 | 300 | 9,177 | 105,705 | 106 K to 105.7 K (-0.28 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.58 | 100 | 3,058 | 106,005 | 106.1 K to 106 K (-0.09 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.58 | 975 | 29,816 | 106,105 | 107.1 K to 106.1 K (-0.91 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.57 | 482 | 14,735 | 107,080 | 107.6 K to 107.1 K (-0.45 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.56 | 500 | 15,280 | 107,562 | 108.1 K to 107.6 K (-0.46 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.54 | 1,000 | 30,540 | 108,062 | 109.1 K to 108.1 K (-0.92 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.53 | 1,100 | 33,583 | 109,062 | 110.2 K to 109.1 K (-1.00 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.52 | 500 | 15,260 | 110,162 | 110.7 K to 110.2 K (-0.45 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.50 | 550 | 16,775 | 110,662 | 111.2 K to 110.7 K (-0.49 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.47 | 100 | 3,047 | 111,212 | 111.3 K to 111.2 K (-0.09 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.45 | 100 | 3,045 | 111,312 | 111.4 K to 111.3 K (-0.09 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.43 | 200 | 6,086 | 111,412 | 111.6 K to 111.4 K (-0.18 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.42 | 100 | 3,042 | 111,612 | 111.7 K to 111.6 K (-0.09 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.41 | 100 | 3,041 | 111,712 | 111.8 K to 111.7 K (-0.09 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.39 | 100 | 3,039 | 111,812 | 111.9 K to 111.8 K (-0.09 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.19 | 300 | 9,357 | 111,912 | 112.2 K to 111.9 K (-0.27 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.19 | 400 | 12,474 | 112,212 | 112.6 K to 112.2 K (-0.36 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.18 | 900 | 28,062 | 112,612 | 113.5 K to 112.6 K (-0.79 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.17 | 600 | 18,702 | 113,512 | 114.1 K to 113.5 K (-0.53 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.16 | 100 | 3,116 | 114,112 | 114.2 K to 114.1 K (-0.09 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.13 | 6 | 187 | 114,212 | 114.2 K to 114.2 K (-0.01 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.06 | 800 | 24,848 | 114,218 | 115 K to 114.2 K (-0.70 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.05 | 1,966 | 61,044 | 115,018 | 117 K to 115 K (-1.68 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.05 | 1,350 | 41,911 | 116,984 | 118.3 K to 117 K (-1.14 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.04 | 200 | 6,208 | 118,334 | 118.5 K to 118.3 K (-0.17 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.04 | 833 | 25,856 | 118,534 | 119.4 K to 118.5 K (-0.70 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.03 | 101 | 3,134 | 119,367 | 119.5 K to 119.4 K (-0.08 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.02 | 100 | 3,102 | 119,468 | 119.6 K to 119.5 K (-0.08 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.01 | 200 | 6,202 | 119,568 | 119.8 K to 119.6 K (-0.17 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.99 | 162 | 5,020 | 119,768 | 119.9 K to 119.8 K (-0.14 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.98 | 100 | 3,098 | 119,930 | 120 K to 119.9 K (-0.08 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.96 | 900 | 27,864 | 120,030 | 120.9 K to 120 K (-0.74 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.96 | 1,000 | 30,955 | 120,930 | 121.9 K to 120.9 K (-0.82 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.95 | 700 | 21,665 | 121,930 | 122.6 K to 121.9 K (-0.57 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Option Exercise | M | 13.06 | 24,885 | 324,998 | 49,771 | |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Option Exercise | M | 28.79 | 7,500 | 215,925 | 0 | |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Option Exercise | M | 27.71 | 5,864 | 162,491 | 17,593 | |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Option Exercise | M | 10.99 | 68,591 | 753,815 | 34,290 | |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Option Exercise | M | 24.27 | 9,525 | 231,172 | 3,175 | |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.95 | 1,200 | 37,134 | 122,630 | 123.8 K to 122.6 K (-0.97 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.90 | 1,200 | 37,080 | 123,830 | 125 K to 123.8 K (-0.96 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.89 | 1,200 | 37,068 | 125,030 | 126.2 K to 125 K (-0.95 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.88 | 1,400 | 43,232 | 126,230 | 127.6 K to 126.2 K (-1.10 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.87 | 200 | 6,174 | 127,630 | 127.8 K to 127.6 K (-0.16 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.86 | 100 | 3,086 | 127,830 | 127.9 K to 127.8 K (-0.08 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.85 | 200 | 6,170 | 127,930 | 128.1 K to 127.9 K (-0.16 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.84 | 100 | 3,084 | 128,130 | 128.2 K to 128.1 K (-0.08 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.83 | 300 | 9,249 | 128,230 | 128.5 K to 128.2 K (-0.23 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.82 | 1,500 | 46,230 | 128,530 | 130 K to 128.5 K (-1.15 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.81 | 2,300 | 70,863 | 130,030 | 132.3 K to 130 K (-1.74 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.80 | 1,300 | 40,040 | 132,330 | 133.6 K to 132.3 K (-0.97 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.79 | 500 | 15,395 | 133,630 | 134.1 K to 133.6 K (-0.37 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.78 | 1,300 | 40,014 | 134,130 | 135.4 K to 134.1 K (-0.96 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.77 | 2,300 | 70,771 | 135,430 | 137.7 K to 135.4 K (-1.67 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.77 | 3,601 | 110,785 | 137,730 | 141.3 K to 137.7 K (-2.55 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.76 | 700 | 21,534 | 141,331 | 142 K to 141.3 K (-0.49 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.76 | 4,500 | 138,420 | 142,031 | 146.5 K to 142 K (-3.07 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.76 | 2,300 | 70,737 | 146,531 | 148.8 K to 146.5 K (-1.55 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.75 | 75,400 | 2,318,550 | 148,831 | 224.2 K to 148.8 K (-33.63 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.68 | 1,000 | 30,680 | 224,231 | 225.2 K to 224.2 K (-0.44 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.68 | 400 | 12,270 | 225,231 | 225.6 K to 225.2 K (-0.18 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.67 | 1,600 | 49,072 | 225,631 | 227.2 K to 225.6 K (-0.70 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.66 | 300 | 9,198 | 227,231 | 227.5 K to 227.2 K (-0.13 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.65 | 746 | 22,865 | 227,531 | 228.3 K to 227.5 K (-0.33 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Buy | M | 13.06 | 24,855 | 324,606 | 228,277 | 203.4 K to 228.3 K (+12.22 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Buy | M | 28.79 | 7,500 | 215,925 | 203,392 | 195.9 K to 203.4 K (+3.83 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Buy | M | 27.71 | 5,864 | 162,491 | 195,892 | 190 K to 195.9 K (+3.09 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Buy | M | 10.99 | 68,591 | 753,815 | 190,028 | 121.4 K to 190 K (+56.48 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Buy | M | 24.27 | 9,525 | 231,172 | 121,437 | 111.9 K to 121.4 K (+8.51 %) |
Jan 13 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Payment of Exercise | F | 35.98 | 21,348 | 768,101 | 111,888 | 133.2 K to 111.9 K (-16.02 %) |
Jan 13 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Grant | A | 0.00 | 21,603 | 0 | 133,236 | 111.6 K to 133.2 K (+19.35 %) |
Jan 10 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Option Exercise | A | 36.54 | 17,740 | 648,220 | 17,740 | |
Jan 10 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Grant | A | 0.00 | 8,870 | 0 | 111,633 | 102.8 K to 111.6 K (+8.63 %) |
Jan 06 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Payment of Exercise | F | 37.79 | 1,062 | 40,133 | 102,763 | 103.8 K to 102.8 K (-1.02 %) |
Dec 22 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Generics | Payment of Exercise | F | 38.26 | 2,496 | 95,497 | 103,825 | 106.3 K to 103.8 K (-2.35 %) |
Nov 19 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Payment of Exercise | F | 37.72 | 14,019 | 528,797 | 106,321 | 120.3 K to 106.3 K (-11.65 %) |
Mar 24 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Generics | Payment of Exercise | F | 25.09 | 2,200 | 55,198 | 120,340 | 122.5 K to 120.3 K (-1.80 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Option Exercise | M | 13.06 | 24,885 | 324,998 | 74,656 | |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.13 | 100 | 2,513 | 122,540 | 122.6 K to 122.5 K (-0.08 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.12 | 300 | 7,536 | 122,640 | 122.9 K to 122.6 K (-0.24 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.11 | 4,800 | 120,528 | 122,940 | 127.7 K to 122.9 K (-3.76 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.10 | 200 | 5,020 | 127,740 | 127.9 K to 127.7 K (-0.16 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.09 | 200 | 5,018 | 127,940 | 128.1 K to 127.9 K (-0.16 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.08 | 100 | 2,508 | 128,140 | 128.2 K to 128.1 K (-0.08 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.08 | 600 | 15,045 | 128,240 | 128.8 K to 128.2 K (-0.47 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.07 | 500 | 12,535 | 128,840 | 129.3 K to 128.8 K (-0.39 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.06 | 100 | 2,506 | 129,340 | 129.4 K to 129.3 K (-0.08 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.06 | 3,600 | 90,216 | 129,440 | 133 K to 129.4 K (-2.71 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.05 | 700 | 17,535 | 133,040 | 133.7 K to 133 K (-0.52 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.04 | 300 | 7,512 | 133,740 | 134 K to 133.7 K (-0.22 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.03 | 100 | 2,503 | 134,040 | 134.1 K to 134 K (-0.07 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.02 | 200 | 5,004 | 134,140 | 134.3 K to 134.1 K (-0.15 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.01 | 600 | 15,006 | 134,340 | 134.9 K to 134.3 K (-0.44 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.00 | 12,485 | 312,125 | 134,940 | 147.4 K to 134.9 K (-8.47 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Buy | M | 13.06 | 24,885 | 324,998 | 147,425 | 122.5 K to 147.4 K (+20.31 %) |
Jan 12 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Generics | Payment of Exercise | F | 25.80 | 1,017 | 26,239 | 122,540 | 123.6 K to 122.5 K (-0.82 %) |
Jan 12 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Generics | Payment of Exercise | F | 25.80 | 1,509 | 38,932 | 123,557 | 125.1 K to 123.6 K (-1.21 %) |
Jan 06 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Generics | Option Exercise | A | 27.71 | 23,457 | 649,993 | 23,457 | |
Jan 06 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Generics | Grant | A | 0.00 | 11,729 | 0 | 125,066 | 113.3 K to 125.1 K (+10.35 %) |
Dec 22 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Generics | Payment of Exercise | F | 26.04 | 1,807 | 47,054 | 113,337 | 115.1 K to 113.3 K (-1.57 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.37 | 300 | 6,111 | 115,144 | 115.4 K to 115.1 K (-0.26 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.35 | 400 | 8,140 | 115,444 | 115.8 K to 115.4 K (-0.35 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.33 | 5,105 | 103,785 | 115,844 | 120.9 K to 115.8 K (-4.22 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.32 | 900 | 18,288 | 120,949 | 121.8 K to 120.9 K (-0.74 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.31 | 500 | 10,155 | 121,849 | 122.3 K to 121.8 K (-0.41 %) |